Azithromycin/favipiravir/hydroxychloroquineVentricular tachycardia and off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82602-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[1] Azithromycin/hydroxychloroquineVentricular arrhythmias following off-label use in COVID-19: 2 case reports
[J]. Reactions Weekly, 2020, 1819 (1) : 61 - 61
[2] Azithromycin/favipiravir/hydroxychloroquineLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1865 (1) : 104 - 104
[3] Favipiravir/hydroxychloroquine/methylprednisoloneNephrotoxicity following an off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1871 (1) : 172 - 172
[4] Azithromycin/hydroxychloroquineQTc prolongation following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1842 (1) : 83 - 83
[5] Azithromycin/hydroxychloroquineCardiac arrest following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 74 - 74
[6] Ceftriaxone/favipiravir/levofloxacinLack of efficacy followed by off-label use: 2 case reports
[J]. Reactions Weekly, 2023, 1945 (1) : 155 - 155
[7] Dexamethasone/favipiravir/methylprednisoloneHyperglycaemia, masking of cytokine storm and off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1872 (1) : 172 - 172
[8] Azithromycin/favipiravir/hydroxychloroquineHypoglycaemia and off label use: case report
[J]. Reactions Weekly, 2021, 1848 (1) : 85 - 85
[9] Azithromycin/hydroxychloroquineQT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1882 (1) : 95 - 95
[10] Azithromycin/ceftriaxone/remdesivirBradycardia and lack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1896 (1) : 79 - 79

← 1 2 3 4 5 →